Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.28
-0.36 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
10.27
-0.01 (-0.10%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 19.43, with a low estimate of 12 and a high estimate of 30. The average target predicts an increase of 89.01% from the current stock price of 10.28.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2026.
Analyst Ratings
The average analyst rating for Vir Biotechnology stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 3 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +94.55% | Mar 4, 2026 |
| Barclays | Barclays | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +191.83% | Feb 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $24 | Buy | Maintains | $20 → $24 | +133.46% | Feb 24, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $12 → $18 | Buy | Maintains | $12 → $18 | +75.10% | Feb 24, 2026 |
| Needham | Needham | Strong Buy Maintains $14 → $18 | Strong Buy | Maintains | $14 → $18 | +75.10% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
253.81M
from 68.56M
Increased by 270.22%
Revenue Next Year
102.48M
from 253.81M
Decreased by -59.62%
EPS This Year
-2.14
from -3.16
EPS Next Year
-2.33
from -2.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 305.5M | 162.4M | ||||||
| Avg | 253.8M | 102.5M | ||||||
| Low | 189.4M | 65.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 345.6% | -36.0% | ||||||
| Avg | 270.2% | -59.6% | ||||||
| Low | 176.2% | -74.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.85 | -1.87 | ||||||
| Avg | -2.14 | -2.33 | ||||||
| Low | -3.43 | -2.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.